NCT06126913 (HeadStART) is a NA clinical trial of Community Antiretroviral Therapy in HIV Infections, sponsored by University of Washington.

Who is sponsoring NCT06126913?

NCT06126913 is sponsored by University of Washington.

What drugs are being tested in NCT06126913?

Interventions in NCT06126913: Community Antiretroviral Therapy.

What condition does NCT06126913 study?

NCT06126913 studies HIV Infections, Hiv.

Is NCT06126913 still recruiting?

NCT06126913 is currently recruiting now. Last updated 9 January 2025.

Last reviewed 2025-01-09 · How we verify

NCT06126913: HeadStART

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

HeadStART: Evaluating the Effectiveness of Community ART Delivery for People Newly Diagnosed With HIV

Recruiting now NA Last updated 9 January 2025

What this trial tests

NA trial testing Community Antiretroviral Therapy in HIV Infections in 2,720 participants. Currently enrolling.

Timeline

15 January 2024

Primary endpoint
31 January 2028

31 January 2028

Quick facts

Lead sponsor	University of Washington
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	2,720
Start date	15 January 2024
Primary completion	31 January 2028
Estimated completion	31 January 2028
Sites	1 location across Uganda

Drugs / interventions tested

Community Antiretroviral Therapy

Conditions studied

HIV Infections — all drugs for HIV Infections →
Hiv — all drugs for Hiv →

Sponsor

University of Washington

Who can join

Eligibility, any sex, with HIV Infections or Hiv. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cluster randomized controlled trial at 12 health centers in refugee settlements in Uganda aiming to evaluate effectiveness of expansion of community antiretroviral therapy (ART) delivery to people newly diagnosed with HIV in achieving HIV viral suppression.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Protocol for Head StART: A hybrid type II cluster randomized controlled trial evaluating community ART delivery for people newly diagnosed with HIV in refugee settlements in Uganda.
Klabbers RE, Mugyenyi A, Nsubuga R, Asaba G, et al · · 2026 · PMID 41758805 · DOI 10.1371/journal.pone.0340916

Verify or expand the search:

Other recruiting trials for HIV Infections

Currently open trials in the same condition.

NCT07225530 — Implementation of Screen, Treat, and Triage for Women Living With HIV in La Romana (iSTAR) · NA · recruiting
NCT07202546 — A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study) · Phase 2 · recruiting
NCT06694753 — Safety and Immunogenicity Study of Three mRNAs Encoding HIV Immunogens in Adult Participants Without HIV and in Overall · Phase 1 · recruiting
NCT07235852 — Pilot Testing Into the Feasibility of the Developed Cognitive Behavioral Therapy Intervention · NA · recruiting
NCT06665646 — Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Ad · Phase 1 · recruiting

Other University of Washington trials

Trials by the same sponsor.

NCT07430852 — Inherited and Environmental Risks Acting on Body Weight · NA · not yet recruiting
NCT07466498 — Estrogen to Improve Quality of Life for Men With Newly Diagnosed or Recurrent Metastatic Hormone Sensitive Prostate Canc · Phase 2 · not yet recruiting
NCT06422299 — Developing and Testing an Online Intervention for Alcohol and Cannabis Misuse and Healthy Relationship Skills Among Youn · NA · not yet recruiting
NCT07322341 — SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer · Phase 2 · not yet recruiting
NCT07332351 — Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06126913 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Washington
Last refreshed: 9 January 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06126913.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing